Veru INC Form 4 insider transactions

Veru Inc. CEO Mitchell Steiner was granted 604,000 stock options with an exercise price of $2.25 per share.

Veru Inc. Chief Administrative Officer and CFO Michele Greco was granted 164,000 stock options with an exercise price of $2.25.

Veru Inc. Director Loren Katzovitz reported the acquisition of 102,000 stock options with an exercise price of $2.25.

Veru Inc. Director Grace Hyun acquired 97,000 stock options with an exercise price of $2.25.

Veru Inc. Director Michael L. Rankowitz acquired 100,000 stock options with an exercise price of $2.25, vesting over three years.

Veru Inc. director Lucy Lu acquired 104,000 stock options with an exercise price of $2.25, vesting over three years.

Gary K. Barnette, Chief Scientific Officer of Veru Inc., reported the acquisition of stock options on May 4, 2026.

Harry Fisch, Chief Corporate Officer and Director of Veru Inc., acquired 160,000 stock options with an exercise price of $2.25.

VERU Inc.'s Chief Scientific Officer, K Gary Barnette, was granted 27,000 stock options with a $2.49 exercise price, vesting over three years.

VERU Inc. Director Michael L. Rankowitz acquired 3,000 common stock options with an exercise price of $2.49, vesting over three years.

VERU Inc. Director Loren Mark Katzovitz acquired 6,000 common stock options with an exercise price of $2.49, vesting over three years.

VERU Inc.'s President and CEO, Mitchell Shuster Steiner, acquired 100,000 common stock options with an exercise price of $2.49.

VERU Inc. Director Grace Hyun acquired 6,000 stock options with an exercise price of $2.49, vesting over three years.

VERU Inc.'s Chief Administrative Officer and CFO, Michele Greco, was granted 27,000 common stock options with an exercise price of $2.49, vesting over three years.

VERU Inc. Director Lucy Lu was granted 4,000 common stock options with an exercise price of $2.49, vesting over three years.

VERU Inc.'s Chief Corporate Officer and Director, Harry Fisch, acquired 27,000 stock options with an exercise price of $2.49, vesting over three years.

VERU Inc. Director Michael L. Rankowitz was granted 7,000 stock options with an exercise price of $3.89, vesting over three years.

VERU Inc. Director Grace Hyun reported the acquisition of 3,000 common stock options with an exercise price of $3.89, vesting over three years.

VERU Inc. Director Lucy Lu was granted 6,000 stock options with an exercise price of $3.89, vesting over three years.

Director Grace Hyun acquired 55,000 stock options in Veru Inc. on May 6, 2025, according to a Form 4 filing.

Director Loren Mark Katzovitz acquired 90,000 common stock options of Veru Inc. at an exercise price of $0.5021 on May 6, 2025.

Michele Greco, Chief Admin Officer and CFO of Veru Inc., reports the acquisition of 108,000 stock options with an exercise price of $0.5021, vesting over three years.

Chief Scientific Officer Barnette K Gary acquired 104,000 common stock options in Veru Inc. on May 6, 2025.

Veru Inc.'s CEO, Mitchell Steiner, reports the acquisition of 378,000 common stock options with an exercise price of $0.5021, vesting over three years and expiring in 2035.

Director Lucy Lu reports acquisition of 30,000 Veru Inc. stock options with a vesting schedule and expiration in 2035.

Harry Fisch, Chief Corporate Officer of Veru Inc., reports the acquisition of 104,000 stock options exercisable at $0.5021, vesting in installments from 2026 to 2028.

Director Michael L. Rankowitz acquired 15,000 common stock options in Veru Inc. on May 6, 2025, exercisable at $0.5021.

Director Grace Hyun acquired options for 5,000 shares of Veru Inc. stock related to her appointment as Chair of the Nominating and Corporate Governance Committee.

Director Loren Mark Katzovitz receives stock options related to his appointment to the Nominating and Corporate Governance committee.

Director Michael L. Rankowitz reports acquiring additional shares of Veru Inc. common stock through open market purchases.